• English
  • العربية
  • 中文
  • Français
  • Русский
  • Español

You are here

Radiopharmaceuticals for Sentinel Lymph Node Detection: Status and Trends

IAEA Radioisotopes and Radiopharmaceuticals Series No. 6

English STI/PUB/1674 ¦ 978-92-0-109714-9

162 pages ¦ 43 figures ¦ € 39.00 ¦ Date published: 2015

Download PDF (2.43 MB)


This book summarizes the current status and future trends in the development of radiopharmaceuticals for sentinel lymph node detection (SLND), an essential diagnostic tool for the effective treatment of superficial cancers such as breast tumours and melanoma. The publication covers all current aspects of this diagnostic methodology, including the production of nanocolloidal particles, their biological mechanism of action and relevant clinical applications. It also illustrates the recent developments in the field fuelled by the introduction of molecular imaging agents for SLND and of multimodality optical and radioactive agents. Included in the results presented in this book, are those on the novel generation of SLND radiopharmaceuticals obtained through an IAEA coordinated research project.

More Information on reusing IAEA copyright material.


IAEA Radioisotopes and Radiopharmaceuticals, Radioactive Tracers, Lymph Nodes, Cancer, Diagnostic Radiopharmaceuticals, Sentinel Lymph Node Detection, SLND, Biopsy, SLNB, Mammary Glands, Melanomas, Lymphatic System

Related publications

Stay in touch